Title:
多発性硬化症治療用のシポニモドとラキニモドを含む組み合わせ
Document Type and Number:
Japanese Patent JP6731915
Kind Code:
B2
Abstract:
The present invention relates to combinations and pharmaceutical compositions comprising siponimod and laquinimod, and the use of said combinations and/or compositions for the treatment of multiple sclerosis, particularly secondary progressive multiple sclerosis.
Inventors:
Smith, Paul Alfred
Application Number:
JP2017520503A
Publication Date:
July 29, 2020
Filing Date:
October 14, 2015
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K31/4704; A61K31/397; A61P25/00; A61P43/00
Foreign References:
| WO2013055907A1 |
Other References:
ACS Medicinal Chemistry Letters,2013年,Vol.4,p.333-337
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Hakoda Mitsuru
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Hakoda Mitsuru
Yasuhito Suzuki